Glucotrack Signs Merger Agreement to Acquire Lohkahi Therapeutics
Glucotrack, Inc. entered into an execution copy of a merger agreement with Lohkahi Therapeutics, Inc. dated July 14, 2026. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval.
View filing at SEC.gov →